Paolo Baldo

14PUBLICATIONS
40CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 21, 2026
Cross-Sectional Multicenter Biomonitoring Study on Genotoxicity and Oxidative DNA Damage in Oncology Healthcare Workers from Seven Italian Hospitals.

Cinzia Lucia Ursini, Giorgia Di Gennaro, Giuliana Buresti

|Nov 26, 2025
Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer.

Riccardo Vida, Michele Bartoletti, Lucia Lerda

|May 25, 2024
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("PEMBROREAL" Study).

Alessandro Cafaro, Flavia Foca, Oriana Nanni

|Jan 23, 2024
Improving Drug Safety in Pediatric and Young Adult Patients with Hemato-Oncological Diseases: A Prospective Study of Active Pharmacovigilance.

Anna Parzianello, Giulia Fornasier, Valentina Kiren

|Dec 14, 2023
How will the identification and therapeutic intervention of genetic targets in oncology evolve for future therapy?

Paolo Baldo, Valli De Re, Mattia Garutti

|Nov 14, 2023
Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case Reports.

Sabrina Orzetti, Paolo Baldo

Pageof 3

Frequent Collaborators

4 joint publications

Sabrina Orzetti

2 joint publications

Giorgia Bortolin

2 joint publications

Elisabetta Caccin

2 joint publications

Sara Cecco